237 related articles for article (PubMed ID: 12837514)
1. Cytotoxicity assessment of three therapeutic agents, cyclosporin-A, cisplatin and doxorubicin, with the ciliated protozoan Tetrahymena pyriformis.
Bonnet JL; Dusser M; Bohatier J; Laffosse J
Res Microbiol; 2003 Jun; 154(5):375-85. PubMed ID: 12837514
[TBL] [Abstract][Full Text] [Related]
2. Use of the ciliated protozoan Tetrahymena pyriformis for the assessment of toxicity and quantitative structure--activity relationships of xenobiotics: comparison with the Microtox test.
Bogaerts P; Bohatier J; Bonnemoy F
Ecotoxicol Environ Saf; 2001 Jul; 49(3):293-301. PubMed ID: 11440483
[TBL] [Abstract][Full Text] [Related]
3. Assessment of the potential toxicity of herbicides and their degradation products to nontarget cells using two microorganisms, the bacteria Vibrio fischeri and the ciliate Tetrahymena pyriformis.
Bonnet JL; Bonnemoy F; Dusser M; Bohatier J
Environ Toxicol; 2007 Feb; 22(1):78-91. PubMed ID: 17295264
[TBL] [Abstract][Full Text] [Related]
4. 2004 Dr. Gary J. Becker Young Investigator Award: Relative thermosensitivity of cytotoxic drugs used in transcatheter arterial chemoembolization.
Ahrar K; Newman RA; Pang J; Vijjeswarapu MK; Wallace MJ; Wright KC
J Vasc Interv Radiol; 2004 Sep; 15(9):901-5. PubMed ID: 15361556
[TBL] [Abstract][Full Text] [Related]
5. Antitumor activity of a new platinum(II) complex with low nephrotoxicity and genotoxicity.
Marzano C; Bettio F; Baccichetti F; Trevisan A; Giovagnini L; Fregona D
Chem Biol Interact; 2004 Jun; 148(1-2):37-48. PubMed ID: 15223355
[TBL] [Abstract][Full Text] [Related]
6. Interactions of doxycycline with chemotherapeutic agents in human breast adenocarcinoma MDA-MB-231 cells.
Foroodi F; Duivenvoorden WC; Singh G
Anticancer Drugs; 2009 Feb; 20(2):115-22. PubMed ID: 19209028
[TBL] [Abstract][Full Text] [Related]
7. Synergistic anti-cancer effects of silibinin with conventional cytotoxic agents doxorubicin, cisplatin and carboplatin against human breast carcinoma MCF-7 and MDA-MB468 cells.
Tyagi AK; Agarwal C; Chan DC; Agarwal R
Oncol Rep; 2004 Feb; 11(2):493-9. PubMed ID: 14719089
[TBL] [Abstract][Full Text] [Related]
8. Anticancer drug resistance induced by disruption of the Saccharomyces cerevisiae NPR2 gene: a novel component involved in cisplatin- and doxorubicin-provoked cell kill.
Schenk PW; Brok M; Boersma AW; Brandsma JA; Den Dulk H; Burger H; Stoter G; Brouwer J; Nooter K
Mol Pharmacol; 2003 Aug; 64(2):259-68. PubMed ID: 12869630
[TBL] [Abstract][Full Text] [Related]
9. Hypoxia-induced resistance to cisplatin and doxorubicin in non-small cell lung cancer is inhibited by silencing of HIF-1alpha gene.
Song X; Liu X; Chi W; Liu Y; Wei L; Wang X; Yu J
Cancer Chemother Pharmacol; 2006 Dec; 58(6):776-84. PubMed ID: 16532342
[TBL] [Abstract][Full Text] [Related]
10. Potentiation of the antiproliferative effect in vitro of doxorubicin, cisplatin and genistein by new analogues of vitamin D.
Siwińska A; Opolski A; Chrobak A; Wietrzyk J; Wojdat E; Kutner A; Szelejewski W; Radzikowski C
Anticancer Res; 2001; 21(3B):1925-9. PubMed ID: 11497279
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of anticancer effects of newly synthesized dihydropyridine derivatives in comparison to verapamil and doxorubicin on T47D parental and resistant cell lines in vitro.
Bazargan L; Fouladdel S; Shafiee A; Amini M; Ghaffari SM; Azizi E
Cell Biol Toxicol; 2008 Apr; 24(2):165-74. PubMed ID: 17805981
[TBL] [Abstract][Full Text] [Related]
12. Toxicity assessment of the herbicides sulcotrione and mesotrione toward two reference environmental microorganisms: Tetrahymena pyriformis and Vibrio fischeri.
Bonnet JL; Bonnemoy F; Dusser M; Bohatier J
Arch Environ Contam Toxicol; 2008 Nov; 55(4):576-83. PubMed ID: 18322725
[TBL] [Abstract][Full Text] [Related]
13. ISTA13-catecholamine toxicity and metabolism in the ciliated protozoan, Tetrahymena pyriformis.
Ud-Daula A; Pfister G; Schramm KW
Environ Toxicol; 2009 Dec; 24(6):549-54. PubMed ID: 19051280
[TBL] [Abstract][Full Text] [Related]
14. [Examination of resistance of lung adenocarcinoma cells to cisplatin by technetium-99m methoxyisobutyl isonitrile].
Hu S; Hu CP; Liang CH
Zhonghua Yi Xue Za Zhi; 2005 Jun; 85(21):1493-8. PubMed ID: 16061030
[TBL] [Abstract][Full Text] [Related]
15. Human primary renal cells as a model for toxicity assessment of chemo-therapeutic drugs.
Li W; Lam M; Choy D; Birkeland A; Sullivan ME; Post JM
Toxicol In Vitro; 2006 Aug; 20(5):669-76. PubMed ID: 16289493
[TBL] [Abstract][Full Text] [Related]
16. Hypothermic modulation of doxorubicin, cisplatin and radiation cytotoxicity in vitro.
Lundgren-Eriksson L; Hultborn R; Henriksson R
Anticancer Res; 2001; 21(5):3275-80. PubMed ID: 11848483
[TBL] [Abstract][Full Text] [Related]
17. Effects of oxidative and nitrosative stress on Tetrahymena pyriformis glyceraldehyde-3-phosphate dehydrogenase.
Fourrat L; Iddar A; Valverde F; Serrano A; Soukri A
J Eukaryot Microbiol; 2007; 54(4):338-46. PubMed ID: 17669159
[TBL] [Abstract][Full Text] [Related]
18. The novel platinum(IV) complex LA-12 induces p53 and p53/47 responses that differ from the related drug, cisplatin.
Hrstka R; Powell DJ; Kvardova V; Roubalova E; Bourougaa K; Candeias MM; Sova P; Zak F; Fåhraeus R; Vojtĕsek B
Anticancer Drugs; 2008 Apr; 19(4):369-79. PubMed ID: 18454047
[TBL] [Abstract][Full Text] [Related]
19. Assessment of the Cytotoxicity of Peptide Modifications of Doxorubicin on Tetrahymena pyriformis.
Pozdnyakova AN; Cheremnykh EG; Sokolov OY; Kost NV; Shevchenko KV; Shevchenko VP; Nagaev IY; Andreeva LA; Myasoedov NF
Dokl Biochem Biophys; 2021 Mar; 497(1):104-107. PubMed ID: 33895924
[TBL] [Abstract][Full Text] [Related]
20. Assessment of anthracene toxicity toward environmental eukaryotic microorganisms: Tetrahymena pyriformis and selected micromycetes.
Bonnet JL; Guiraud P; Dusser M; Kadri M; Laffosse J; Steiman R; Bohatier J
Ecotoxicol Environ Saf; 2005 Jan; 60(1):87-100. PubMed ID: 15482845
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
